[Adams AL, Hudson A, Ryan CL, Doucette TA. Effects of estrous stage and time of day on prepulse inhibition in female rats. J Neurosci Methods 173, 295–298, 2008.10.1016/j.jneumeth.2008.06.014]Search in Google Scholar
[Aliczki M, Fodor A, Balogh Z, Haller J, Zelena D. The effects of lactation on impulsive behavior in vasopressin-deficient Brattleboro rats. Horm Behav 66, 545–551, 2014.10.1016/j.yhbeh.2014.08.002]Search in Google Scholar
[Bakharev VD, Tikhomirov SM, Papsuevich OS, Chipens GI. [Use of vasopressin the treatment of the paranoid form of schizophrenia]. Zh Nevropatol Psikhiatr Im S S Korsakova 84, 88–92, 1984.]Search in Google Scholar
[Bohus B, de Wied D. The vasopressin deficient Brattleboro rats: a natural knockout model used in the search for CNS effects of vasopressin. Prog Brain Res 119, 555–573, 1998.10.1016/S0079-6123(08)61593-9]Search in Google Scholar
[Brambilla F, Aguglia E, Massironi R, Maggioni M, Grillo W, Castiglioni R, Catalano M, Drago F. Neuropeptide therapies in chronic schizophrenia: TRH and vasopressin administration. Neuropsychobiology 15, 114–121, 1986.10.1159/000118253]Search in Google Scholar
[Brambilla F, Bondiolotti GP, Maggioni M, Sciascia A, Grillo W, Sanna F, Latina A, Picotti GB. Vasopressin (DDAVP) therapy in chronic schizophrenia: effects on negative symptoms and memory. Neuropsychobiology 20, 113–119, 1989.10.1159/000118483]Search in Google Scholar
[Caldwell HK, Lee HJ, Macbeth AH, Young WS, 3rd. Vasopressin: behavioral roles of an “original” neuropeptide. Prog Neurobiol 84, 1–24, 2008.10.1016/j.pneurobio.2007.10.007]Search in Google Scholar
[Chabot CC, Taylor DH. Circadian modulation of the rat acoustic startle response. Behav Neurosci 106, 846–852, 1992.10.1037/0735-7044.106.5.846]Search in Google Scholar
[Cilia J, Gartlon JE, Shilliam C, Dawson LA, Moore SH, Jones DN. Further neurochemical and behavioural investigation of Brattleboro rats as a putative model of schizophrenia. J Psychopharmacol 24, 407–419, 2010.10.1177/0269881108098787]Search in Google Scholar
[da Silva TL, Ravindran AV. Contribution of sex hormones to gender differences in schizophrenia: A review. Asian J Psychiatr 18, 2–14, 2015.10.1016/j.ajp.2015.07.016]Search in Google Scholar
[Decaux G, Soupart A, Vassart G. Non-peptide arginine-vasopressin antagonists: the vaptans. Lancet 371, 1624–1632, 2008.10.1016/S0140-6736(08)60695-9]Search in Google Scholar
[Elman I, Lukas S, Shoaf SE, Rott D, Adler C, Breier A. Effects of acute metabolic stress on the peripheral vasopressinergic system in schizophrenia. J Psychopharmacol 17, 317–323, 2003.10.1177/02698811030173014]Search in Google Scholar
[Engelmann M, Landgraf R. Microdialysis administration of vasopressin into the septum improves social recognition in Brattleboro rats. Physiol Behav 55, 145–149, 1994.10.1016/0031-9384(94)90022-1]Search in Google Scholar
[Feifel D, Priebe K. Vasopressin-deficient rats exhibit sensorimotor gating deficits that are reversed by subchronic haloperidol. Biol Psychiatry 50, 425–433, 2001.10.1016/S0006-3223(01)01100-3]Search in Google Scholar
[Feifel D, Melendez G, Shilling PD. Reversal of sensorimotor gating deficits in Brattleboro rats by acute administration of clozapine and a neurotensin agonist, but not haloperidol: a potential predictive model for novel anti-psychotic effects. Neuropsychopharmacology 29, 731–738, 2004.10.1038/sj.npp.130037814760394]Search in Google Scholar
[Feifel D, Priebe K. The effects of cross-fostering on inherent sensorimotor gating deficits exhibited by Brattleboro rats. J Gen Psychol 134, 173–182, 2007.10.3200/GENP.134.2.172-18217503693]Search in Google Scholar
[Feifel D, Melendez G, Priebe K, Shilling PD. The effects of chronic administration of established and putative anti-psychotics on natural prepulse inhibition deficits in Brattleboro rats. Behav Brain Res 181, 278–286, 2007.10.1016/j.bbr.2007.04.02017559953]Search in Google Scholar
[Feifel D, Shilling PD, Melendez G. Further characterization of the predictive validity of the Brattleboro rat model for antipsychotic efficacy. J Psychopharmacol 25, 836–841, 2011.10.1177/0269881110388327420971721106605]Search in Google Scholar
[Fodor A, Barsvari B, Aliczki M, Balogh Z, Zelena D, Goldberg SR, Haller J. The effects of vasopressin deficiency on aggression and impulsiveness in male and female rats. Psychoneuroendocrinology 47, 141–150, 2014.10.1016/j.psyneuen.2014.05.01025001964]Search in Google Scholar
[Forizs L. Treatment of mental patients with antidiuretic hormone of the posterior pituitary. Dis Nerv Syst 13, 44–47, 1952a.]Search in Google Scholar
[Forizs L. The use of pitressin in the treatment of schizophrenia with deterioration. N C Med J 13, 76–80, 1952b.]Search in Google Scholar
[Frankland PW, Ralph MR. Circadian modulation in the rat acoustic startle circuit. Behav Neurosci 109, 43–48, 1995.10.1037/0735-7044.109.1.43]Search in Google Scholar
[Frederiksen SO, Ekman R, Gottfries CG, Widerlov E, Jonsson S. Reduced concentrations of galanin, arginine vasopressin, neuropeptide Y and peptide YY in the temporal cortex but not in the hypothalamus of brains from schizophrenics. Acta Psychiatr Scand 83, 273–277, 1991.10.1111/j.1600-0447.1991.tb05539.x1709331]Search in Google Scholar
[Geyer MA, Krebs-Thomson K, Braff DL, Swerdlow NR. Pharmacological studies of prepulse inhibition models of sensorimotor gating deficits in schizophrenia: a decade in review. Psychopharmacology (Berl) 156, 117–154, 2001.10.1007/s002130100811]Search in Google Scholar
[Goldman MB, Robertson GL, Luchins DJ, Hedeker D, Pandey GN. Psychotic exacerbations and enhanced vasopressin secretion in schizophrenic patients with hyponatremia and polydipsia. Arch Gen Psychiatry 54, 443–449, 1997.10.1001/archpsyc.1997.01830170069010]Search in Google Scholar
[Golimbet V, Alfimova M, Abramova L, Kaleda V, Gritsenko I. Arginine vasopressin 1a receptor RS3 promoter microsatellites in schizophrenia: a study of the effect of the “risk” allele on clinical symptoms and facial affect recognition. Psychiatry Res 225, 739–740, 2015.10.1016/j.psychres.2014.11.043]Search in Google Scholar
[Horlington M. Startle response circadian rhythm in rats: lack of correlation with motor activity. Physiol Behav 5, 49–53, 1970.10.1016/0031-9384(70)90012-0]Search in Google Scholar
[Hosseini SM, Farokhnia M, Rezaei F, Gougol A, Yekehtaz H, Iranpour N, Salehi B, Tabrizi M, Tajdini M, Ghaleiha A, Akhondzadeh S. Intranasal desmopressin as an adjunct to risperidone for negative symptoms of schizophrenia: a randomized, double-blind, placebo-controlled, clinical trial. Eur Neuropsychopharmacol 24, 846–855, 2014.10.1016/j.euroneuro.2014.02.00124636461]Search in Google Scholar
[Iager AC, Kirch DG, Bigelow LB, Karson CN. Treatment of schizophrenia with a vasopressin analogue. Am J Psychiatry 143, 375–377, 1986.10.1176/ajp.143.3.3753513631]Search in Google Scholar
[Jiang X, Zhang ZJ, Zhang S, Gamble EH, Jia M, Ursano RJ, Li H. 5-HT2A receptor antagonism by MDL 11,939 during inescapable stress prevents subsequent exaggeration of acoustic startle response and reduced body weight in rats. J Psychopharmacol 25, 289–297, 2011.10.1177/026988110910691119889890]Search in Google Scholar
[Jobst A, Dehning S, Ruf S, Notz T, Buchheim A, Henning-Fast K, Meissner D, Meyer S, Bondy B, Muller N, Zill P. Oxytocin and vasopressin levels are decreased in the plasma of male schizophrenia patients. Acta Neuropsychiatr 26, 347–355, 2014.10.1017/neu.2014.2025288094]Search in Google Scholar
[Kohl S, Heekeren K, Klosterkotter J, Kuhn J. Prepulse inhibition in psychiatric disorders--apart from schizophrenia. J Psychiatr Res 47, 445–452, 2013.10.1016/j.jpsychires.2012.11.01823287742]Search in Google Scholar
[Korsgaard S, Casey DE, Damgaard Pedersen NE, Jorgensen A, Gerlach J. Vasopressin in anergic schizophrenia. A cross-over study with lysine-8-vasopressin and placebo. Psychopharmacology (Berl) 74, 379–382, 1981.10.1007/BF004327526794086]Search in Google Scholar
[Kumari V, Sharma T. Effects of typical and atypical antipsychotics on prepulse inhibition in schizophrenia: a critical evaluation of current evidence and directions for future research. Psychopharmacology (Berl) 162, 97–101, 2002.10.1007/s00213-002-1099-x]Search in Google Scholar
[Le T, Xia M, Jia M, Sarkar N, Chen J, Li H, Wynn GH, Ursano RJ, Choi KH. Association between initial morphine intake and body weight change, acoustic startle reflex and drug seeking in rats. Psychopharmacology (Berl) 231, 4569–4577, 2014.10.1007/s00213-014-3606-2]Search in Google Scholar
[Lehmann J, Pryce CR, Feldon J. Sex differences in the acoustic startle response and prepulse inhibition in Wistar rats. Behav Brain Res 104, 113–117, 1999.10.1016/S0166-4328(99)00058-3]Search in Google Scholar
[Lehtinen EK, Ucar E, Glenthoj BY, Oranje B. Effects of melatonin on prepulse inhibition, habituation and sensitization of the human startle reflex in healthy volunteers. Psychiatry Res 216, 418–423, 2014.10.1016/j.psychres.2014.02.03024613047]Search in Google Scholar
[Levin R, Heresco-Levy U, Bachner-Melman R, Israel S, Shalev I, Ebstein RP. Association between arginine vasopressin 1a receptor (AVPR1a) promoter region polymorphisms and prepulse inhibition. Psychoneuroendocrinology 34, 901–908, 2009.10.1016/j.psyneuen.2008.12.01419195791]Search in Google Scholar
[Linkowski P, Geenen V, Kerkhofs M, Mendlewicz J, Legros JJ. Cerebrospinal fluid neurophysins in affective illness and in schizophrenia. Eur Arch Psychiatry Neurol Sci 234, 162–165, 1984.10.1007/BF004615556489403]Search in Google Scholar
[Mai JK, Berger K, Sofroniew MV. Morphometric evaluation of neurophysin-immunoreactivity in the human brain: pronounced inter-individual variability and evidence for altered staining patterns in schizophrenia. J Hirnforsch 34, 133–154, 1993.]Search in Google Scholar
[Mendrek A. Is It Important to Consider Sex and Gender in Neurocognitive Studies? Front Psychiatry 6, 83, 2015.10.3389/fpsyt.2015.00083445157726082728]Search in Google Scholar
[Mlynarik M, Zelena D, Bagdy G, Makara GB, Jezova D. Signs of attenuated depression-like behavior in vasopressin deficient Brattleboro rats. Horm Behav 51, 395–405, 2007.10.1016/j.yhbeh.2006.12.00717258216]Search in Google Scholar
[Ohsawa H, Kishimoto T, Shimayoshi N, Matsumura K, Tahara K, Kitera K, Higashiura N, Noriyama Y, Matsumoto H, Hirai M, Ikawa G. Atrial natriuretic peptide and arginine vasopressin secretion in schizophrenic patients. Acta Psychiatr Scand 88, 130–134, 1993.10.1111/j.1600-0447.1993.tb03426.x8213206]Search in Google Scholar
[Pulliam JV, Dawaghreh AM, Alema-Mensah E, Plotsky PM. Social defeat stress produces prolonged alterations in acoustic startle and body weight gain in male Long Evans rats. J Psychiatr Res 44, 106–111, 2010.10.1016/j.jpsychires.2009.05.005281334419573876]Search in Google Scholar
[Reilly W, Koirala B, Devaud LL. Sex differences in acoustic startle responses and seizure thresholds between ethanol-withdrawn male and female rats. Alcohol Alcohol 44, 561–566, 2009.10.1093/alcalc/agp049]Search in Google Scholar
[Robinson GE. Treatment of schizophrenia in pregnancy and postpartum. J Popul Ther Clin Pharmacol 19, e380–e386, 2012.]Search in Google Scholar
[Rubin LH, Carter CS, Bishop JR, Pournajafi-Nazarloo H, Drogos LL, Hill SK, Ruocco AC, Keedy SK, Reilly JL, Keshavan MS, Pearlson GD, Tamminga CA, Gershon ES, Sweeney JA. Reduced levels of vasopressin and reduced behavioral modulation of oxytocin in psychotic disorders. Schizophr Bull 40, 1374–1384, 2014.10.1093/schbul/sbu027]Search in Google Scholar
[Seeman MV. Clinical interventions for women with schizophrenia: pregnancy. Acta Psychiatr Scand 127, 12–22, 2013.10.1111/j.1600-0447.2012.01897.x]Search in Google Scholar
[Shilling PD, Kinkead B, Murray T, Melendez G, Nemeroff CB, Feifel D. Upregulation of striatal dopamine-2 receptors in Brattleboro rats with prepulse inhibition deficits. Biol Psychiatry 60, 1278–1281, 2006.10.1016/j.biopsych.2006.03.045]Search in Google Scholar
[Swerdlow NR, Geyer MA. Using an animal model of deficient sensorimotor gating to study the pathophysiology and new treatments of schizophrenia. Schizophr Bull 24, 285–301, 1998.10.1093/oxfordjournals.schbul.a033326]Search in Google Scholar
[Teltsh O, Kanyas-Sarner K, Rigbi A, Greenbaum L, Lerer B, Kohn Y. Oxytocin and vasopressin genes are significantly associated with schizophrenia in a large Arab-Israeli pedigree. Int J Neuropsychopharmacol 15, 309–319, 2012.10.1017/S1461145711001374]Search in Google Scholar
[Weiss IC, Feldon J, Domeney AM. Circadian time does not modify the prepulse inhibition response or its attenuation by apomorphine. Pharmacol Biochem Behav 64, 501–505, 1999a.10.1016/S0091-3057(99)00100-8]Search in Google Scholar
[Weiss IC, Feldon J, Domeney AM. Isolation rearing-induced disruption of prepulse inhibition: further evidence for fragility of the response. Behav Pharmacol 10, 139–149, 1999b.10.1097/00008877-199903000-0000310780827]Search in Google Scholar
[Yang SY, Hong CJ, Huang YH, Tsai SJ. The effects of glycine transporter I inhibitor, N-methylglycine (sarcosine), on ketamine-induced alterations in sensorimotor gating and regional brain c-Fos expression in rats. Neurosci Lett 469, 127–130, 2010.10.1016/j.neulet.2009.11.05819944746]Search in Google Scholar
[Zelena D, Langnaese K, Domokos A, Pinter O, Landgraf R, Makara GB, Engelmann M. Vasopressin administration into the paraventricular nucleus normalizes plasma oxytocin and corticosterone levels in Brattleboro rats. Endocrinology 150, 2791–2798, 2009.10.1210/en.2008-100719246538]Search in Google Scholar